The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

J Bousquet; S Arnavielhe; A Bedbrook; J Fonseca; M Morais Almeida; A Todo Bom; I Annesi-Maesano; D Caimmi; P Demoly; P Devillier; V Siroux; E Menditto; G Passalacqua; C Stellato; M T Ventura; A A Cruz; F Sarquis Serpa; J da Silva; D Larenas-Linnemann; M Rodriguez Gonzalez; M T Burguete Cabañas; K C Bergmann; T Keil; L Klimek; R Mösges; S Shamai; T Zuberbier; M Bewick; D Price; D Ryan; A Sheikh; J M Anto; J Mullol; A Valero; T Haahtela; E Valovirta; W J Fokkens; P Kuna; B Samolinski; C Bindslev-Jensen; E Eller; S Bosnic-Anticevich; R E O'Hehir; P V Tomazic; A Yorgancioglu; B Gemicioglu; C Bachert; P W Hellings; I Kull; E Melén; M Wickman; M van Eerd; G De Vries; MASK study group

doi:10.1111/all.13307

The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

Allergy. 2018 Feb;73(2):505-510. doi: 10.1111/all.13307. Epub 2017 Oct 5.

Authors

J Bousquet^{1

2

3}, S Arnavielhe⁴, A Bedbrook¹, J Fonseca^{5

6}, M Morais Almeida⁷, A Todo Bom⁸, I Annesi-Maesano⁹, D Caimmi¹⁰, P Demoly¹⁰, P Devillier¹¹, V Siroux¹², E Menditto¹³, G Passalacqua¹⁴, C Stellato¹⁵, M T Ventura¹⁶, A A Cruz¹⁷, F Sarquis Serpa¹⁸, J da Silva¹⁹, D Larenas-Linnemann²⁰, M Rodriguez Gonzalez²¹, M T Burguete Cabañas²², K C Bergmann^{23

24}, T Keil^{25

26}, L Klimek²⁷, R Mösges²⁸, S Shamai²⁸, T Zuberbier^{23

24}, M Bewick²⁹, D Price^{30

31

32}, D Ryan³³, A Sheikh³⁴, J M Anto^{35

36

37}, J Mullol⁷, A Valero³⁸, T Haahtela³⁹, E Valovirta³⁸, W J Fokkens⁴⁰, P Kuna⁴¹, B Samolinski⁴², C Bindslev-Jensen⁴³, E Eller⁴³, S Bosnic-Anticevich⁴⁴, R E O'Hehir^{45

46}, P V Tomazic⁴⁷, A Yorgancioglu^{48

49}, B Gemicioglu⁵⁰, C Bachert⁵¹, P W Hellings⁵², I Kull⁵³, E Melén⁵³, M Wickman⁵⁴, M van Eerd⁵⁵, G De Vries⁵⁵; MASK study group

Affiliations

¹ MACVIA-France, Contre les MAladies Chroniques Pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
² INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, France.
³ UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, Montigny le Bretonneux, France.
⁴ Kyomed, Montpellier, France.
⁵ Faculdade de Medicina, Center for Health Technology and Services Research- CINTESIS, Universidade do Porto, Porto, Portugal.
⁶ Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal.
⁷ Allergy Center, CUF-Descobertas Hospital, Lisboa, Portugal.
⁸ Faculty of Medicine, Imunoalergologia, Centro Hospitalar Universitário de Coimbra, University of Coimbra, Coimbra, Portugal.
⁹ EPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
¹⁰ UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, CHRU de Montpellier, Sorbonne Universités, Paris, France.
¹¹ Laboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Université Versailles Saint-Quentin, Suresnes, France.
¹² INSERM, IAB, U 1209, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Université Joseph Fourier, Université Grenoble Alpes, Grenoble, France.
¹³ CIRFF, Center of Pharmacoeconomics, University of Naples Federico II, Naples, Italy.
¹⁴ Personalized Medicine Clinic Asthma & Allergy, Humanitas Research Hospital, Humanitas University, Milan, Italy.
¹⁵ Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
¹⁶ Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
¹⁷ ProAR - Nucleo de Excelencia em Asma, Brasil and GARD Executive Committee, Federal University of Bahia, Salvador, Brazil.
¹⁸ Asthma Reference Center, Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria, Vitória, Brazil.
¹⁹ Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianopolis, Brazil.
²⁰ Center of Excellence in Asthma and Allergy, Hospital Médica Sur, México, Mexico.
²¹ Pediatric Allergy and Clinical Immunology, Hospital Angeles Pedregal, Mexico City, Mexico.
²² Centro Médico Zambrano Hellion, Monterrey, Mexico.
²³ Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
²⁴ Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany.
²⁵ Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
²⁶ Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany.
²⁷ Center for Rhinology and Allergology, Wiesbaden, Germany.
²⁸ Medical Faculty, Institute of Medical Statistics, Informatics and Epidemiology, University of Cologne, Cologne, Germany.
²⁹ iQ4U Consultants Ltd, London, UK.
³⁰ Observational and Pragmatic Research Institute, Singapore, Singapore.
³¹ Optimum Patient Care, Cambridge, UK.
³² Academic Centre of Primary Care, University of Aberdeen, Aberdeen, UK.
³³ Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
³⁴ Asthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
³⁵ Centre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
³⁶ IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
³⁷ CIBER Epidemiología y Salud Pública (CIBERESP) & Universitat Pompeu Fabra (UPF), Barcelona, Spain.
³⁸ Pneumology and Allergy Department Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
³⁹ Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
⁴⁰ Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, the Netherlands.
⁴¹ Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
⁴² Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Poland.
⁴³ Department of Dermatology and Allergy Centre, Odense University Hospital, Odense Research Center for Anaphylaxis (ORCA), Odense, Denmark.
⁴⁴ Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia.
⁴⁵ Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
⁴⁶ Department of Immunology, Monash University, Melbourne, VIC, Australia.
⁴⁷ Department of ENT, Medical University of Graz, Graz, Austria.
⁴⁸ Department of Pulmonology, Celal Bayar University, Manisa, Turkey.
⁴⁹ GARD Executive Committee, Manisa, Turkey.
⁵⁰ Cerrahpasa Faculty of Medicine, Department of Pulmonary Diseases, Istanbul University, Istanbul, Turkey.
⁵¹ Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
⁵² Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium.
⁵³ Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
⁵⁴ Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
⁵⁵ Peercode DV, Gerdermalsen, the Netherlands.

PMID: 28906011
DOI: 10.1111/all.13307

Abstract

Mobile technology has been used to appraise allergic rhinitis control, but more data are needed. To better assess the importance of mobile technologies in rhinitis control, the ARIA (Allergic Rhinitis and its Impact on Asthma) score ranging from 0 to 4 of the Allergy Diary was compared with EQ-5D (EuroQuol) and WPAI-AS (Work Productivity and Activity Impairment in allergy) in 1288 users in 18 countries. This study showed that quality-of-life data (EQ-5D visual analogue scale and WPA-IS Question 9) are similar in users without rhinitis and in those with mild rhinitis (scores 0-2). Users with a score of 3 or 4 had a significant impairment in quality-of-life questionnaires.

Keywords: Allergic Rhinitis and its Impact on Asthma; EuroQuol; MACVIA-ARIA Sentinel NetworK; Work Productivity and Activity Impairment in allergy; rhinitis.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Asthma / complications*
Cross-Sectional Studies
Europe
Female
Humans
Male
Mobile Applications*
Pilot Projects
Quality of Life*
Rhinitis, Allergic / complications*
Surveys and Questionnaires*
Work Performance

Grants and funding

G1000758/MRC_/Medical Research Council/United Kingdom